Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chronic Lymphocytic Leukemia
100%
Extracellular Vesicles
100%
Immune Landscape
66%
Microenvironment
66%
Non-immunoglobulin
33%
Diagnostic Potential
33%
Overexpression
33%
B-cell Malignancies
33%
Activation-induced Deaminase
33%
Human Neoplasm
33%
Therapeutic Potential
33%
Immune Cells
22%
Tumor-derived Extracellular Vesicles
20%
Chronic Lymphocytic Leukemia Cells
14%
Disease Progression
13%
MicroRNA
12%
Leukemia Patients
11%
B Cells
11%
Mouse Model
8%
Proposed Strategy
6%
Drug Delivery Mechanism
6%
Neoplasia
6%
Pro-tumor
6%
Engineered Extracellular Vesicles
6%
FasL
6%
Cell-cell Communication
6%
Immune-related
6%
Exosomes
6%
Programmed Death-ligand 1 (PD-L1)
6%
Biological Fluids
6%
Cancer Cells
6%
Therapeutic Strategies
6%
Potential Biomarkers
6%
Microvesicles
6%
TCL1
6%
Tumor Cells
6%
Tumor Microenvironment
6%
Disease Stage
6%
Microenvironment Cells
6%
B Lymphocytes
6%
In Cancer
6%
DNA mutation
6%
Oncology
6%
Biogenesis
6%
Cancer Progression
6%
Cargo
6%
Vesicular Content
5%
Extracellular Vesicle Isolation
5%
Immune Targets
5%
Monocytes
5%
Intercellular Communication
5%
CD4-CD8 Ratio
5%
Small Molecules
5%
Cell Resistance
5%
Leukemia Mice
5%
Patient Cohort
5%
Resistance to Treatment
5%
Functional Impact
5%
Leukocytosis
5%
Cytokine Production
5%
Next-generation Sequencing
5%
Expressed Genes
5%
Spleen
5%
Serum Samples
5%
Cell Survival
5%
Small RNA (sRNA)
5%
Y RNA
5%
Transcriptome
5%
Inflammation Condition
5%
CD8 T Cells
5%
Proliferation Apoptosis
5%
Prognostic Biomarker
5%
Immunology and Microbiology
B Cell
66%
Immune Landscape
66%
Immunocompetent Cell
66%
Ribonucleic Acid
50%
Leukemia Cell
33%
Cell Communication
33%
Mouse Model
16%
Next Generation Sequencing
16%
Cytotoxic T-Cell
16%
Blood Plasma
16%
Exosome
16%
CD4
16%
Cytokine Production
16%
Transcriptomics
16%
Internalization
16%
Cell Survival
16%
Programmed Death-Ligand 1
16%
Tumor Cell
16%
Target Cell
16%
Prognostic Biomarker
16%
Cancer Cell
16%
Biogenesis
16%
Programmed Cell Death
16%
Inflammation
16%
Monocyte
16%
In Vitro
16%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Neoplasm
33%
Activation Induced Cytidine Deaminase
33%
Immunocompetent Cell
29%
Leukemia Cell
18%
B Cell
10%
Biological Marker
7%
microRNA
7%
Cell Communication
7%
In Vitro
7%
Cytokine Production
7%
Next Generation Sequencing
7%
Transcriptomics
7%
Leukocytosis
7%
Programmed Cell Death
7%
Cytotoxic T-Cell
7%
Cell Survival
7%
Target Cell
7%
Inflammation
7%
Monocyte
7%
Cancer
6%
Malignant Neoplasm
6%
Disease Exacerbation
6%
B Lymphocyte
6%
DNA Mutation
6%
Diseases
6%